Study on the Therapeutic Efficacy of Subcutaneous Semaglutide Injection in Patients with Fatty Liver Complicated by Obesity
Not Applicable
- Conditions
- Fatty Liver Complicated by Obesity
- Registration Number
- JPRN-UMIN000052061
- Lead Sponsor
- agoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Those who cannot give consent for this study, or those who are expected to have a poor long-term prognosis due to liver failure or malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Whether or not obesity and fatty liver are improved, and information on side effects
- Secondary Outcome Measures
Name Time Method